Post‐ FDA Approval Experience With Momelotinib in JAK Inhibitor‐Naïve Myelofibrosis: Focus on Anemia Response and Treatment‐Emergent Nephropathy and Peripheral Neuropathy

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Ayalew Tefferi, Maymona Abdelmagid, Jeanne M. Palmer, Aref Al‐Kali, Cecilia Y. Arana Yi, Aasiya Matin, Hassan B. Alkhateeb, Talha Badar, Yassin Bashir, Kaaren K. Reichard, Rong He, Animesh Pardanani, Naseema Gangat
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	American Journal of Hematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet